Skip to main content
Toggle navigation
Login
Search
Home
Conference Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Like
Tweet
Phillip Spinosa, n/a
Principal Scientist
Genentech, Inc.
Poster(s):
(T-113) QSP model trained on preclinical data informs clinical dose selection for a T-cell engaging bispecific antibody for solid tumor indications
Tuesday, November 12, 2024
7:00 AM – 5:00 PM
MST
